Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KNS-366 by Kynos Therapeutics for Pancreatitis: Likelihood of Approval
KNS-366 is under clinical development by Kynos Therapeutics and currently in Phase I for Pancreatitis. According to GlobalData, Phase I...